Neuramis Deep (with Lidocaine)

Neuramis

Aesthetic / Medical Device

Hyaluronic Acid Dermal Filler (Deep volumising / wrinkle correction)

CE marked (manufacturer/distributor claims for Neuramis series in EU/EEA markets).
Manufactured in facilities claiming compliance with regional regulatory standards and quality controls (manufacturer: Medytox).
Hyaluronic acid raw material registered in DMF/EDQM or equivalent per manufacturer/distributor statements (verify local regulatory documentation).

CE marked (manufacturer/distributor claims for Neuramis series in EU/EEA markets).
Manufactured in facilities claiming compliance with regional regulatory standards and quality controls (manufacturer: Medytox).
Hyaluronic acid raw material registered in DMF/EDQM or equivalent per manufacturer/distributor statements (verify local regulatory documentation).

Hyaluronic Acid Dermal Filler (Deep volumising / wrinkle correction)

Description

Neuramis Deep with Lidocaine is a stabilized, cross-linked hyaluronic acid (HA) dermal filler formulated for correction of moderate-to-deep facial wrinkles and for volume augmentation of cheeks, chin and lips. The product contains HA at 20 mg/mL and includes lidocaine (0.3%) in the gel to improve injection comfort. It is supplied as single-use prefilled 1 mL syringes and is intended for intradermal/subcutaneous injection by trained medical professionals.

Bnefits

High HA concentration (20 mg/mL) for deeper volume replacement and correction of folds.
Includes lidocaine (0.3%) for reduced injection pain and improved patient comfort.
SHAPE™ two-step cross-linking and purification process (manufacturer claim) for gel stability and long-lasting effect.
Designed for natural-looking correction of nasolabial folds, marionette lines, cheek/chin augmentation and lip contouring.
Low residual BDDE levels per manufacturer quality specifications.

Indications

Correction of moderate-to-severe facial wrinkles and folds (e.g., nasolabial folds).
Volume augmentation (cheeks, chin, jawline) and lip enhancement where a deeper filler is indicated.
Use by qualified medical practitioners for aesthetic facial procedures.

Composition

Hyaluronic acid (cross-linked) — 20 mg/mL (2.0% w/v)
Lidocaine (as hydrochloride) — 0.3% w/w (which corresponds to approximately 3 mg/mL)
Crosslinking agent residuals present at levels compliant with manufacturer quality controls (BDDE residuals reported as very low by manufacturer)
Excipients and sterile water for injection (complete INCI/IFU available in manufacturer documentation)